Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency

NCT00911625 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Renal Insufficiency

Interventions

DRUG: 0.5 units/kg daily insulin
DRUG: 0.25 units/kg daily insulin

Sponsor

Loyola University

Collaborators

[object Object]